Sharad Ghamande is principal investigator on a study of a monoclonal antibody that prompts the immune system to target wayward ovarian cancer cells roaming the body in an effort to forestall cancer...

Source: 2004 Annual Report [www.mcghealth.org]

note- we don't know that Dr. Ghamande is BHANTU or not. if u have any information pls. inform us